MG53 participates in ischaemic postconditioning through the RISK signalling pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MG53 participates in ischaemic postconditioning through the RISK signalling pathway

Published:2011-02-01 Issue:1 Volume:91 Page:108-115
ISSN:1755-3245
Container-title:Cardiovascular Research
language:en
Short-container-title:

Author:

Zhang Yan,Lv Fengxiang,Jin Li,Peng Wei,Song Ruisheng,Ma Jianjie,Cao Chun-Mei,Xiao Rui-Ping

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine,Physiology

Link

http://academic.oup.com/cardiovascres/article-pdf/91/1/108/17391859/cvr029.pdf

Reference22 articles.

1. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium;Murry;Circulation,1986

2. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning;Zhao;Am J Physiol Heart Circ Physiol,2003

3. Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway;Lacerda;Cardiovasc Res,2009

4. Postconditioning: a form of “modified reperfusion” protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway;Tsang;Circ Res,2004

5. Postconditioning inhibits mitochondrial permeability transition;Argaud;Circulation,2005

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MG53 inhibits ferroptosis by targeting the p53/SLC7A11/GPX4 pathway to alleviate doxorubicin-induced cardiotoxicity;Free Radical Biology and Medicine;2024-10

2. p85α deficiency alleviates ischemia-reperfusion injury by promoting cardiomyocyte survival;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-10

3. Pathogenic mechanisms of disease in idiopathic inflammatory myopathies: autoantibodies as clues;Frontiers in Immunology;2024-08-30

4. MG53 binding to CAV3 facilitates activation of eNOS/NO signaling pathway to enhance the therapeutic benefits of bone marrow-derived mesenchymal stem cells in diabetic wound healing;International Immunopharmacology;2024-07

5. MG53: A new protagonist in the precise treatment of cardiomyopathies;Biochemical Pharmacology;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3